Skip to content

Drug interactions

Alpelisib + Glipizide-metformin

Severity: Moderate

Alpelisib and Glipizide-metformin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Alpelisib may induce CYP2C9 and lower glipizide exposure, potentially weakening glucose control. Alpelisib itself commonly causes hyperglycemia, which can further complicate diabetes management.

What this interaction means in plain words

Alpelisib and Glipizide-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Alpelisib belongs to Oncology; Glipizide-metformin belongs to Endocrine.

Evidence level: Moderate

Why it happens

Alpelisib induces CYP2C9, increasing glipizide metabolism, and PI3K inhibition causes hyperglycemia.

What to do

Monitor blood glucose frequently during alpelisib therapy and increase antidiabetic therapy as needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Alpelisib and Glipizide-metformin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Alpelisib with Glipizide-metformin?

MediHelp rates the interaction as moderate. Alpelisib and Glipizide-metformin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Alpelisib may induce CYP2C9 and lower glipizide exposure, potentially weakening glucose control. Alpelisib itself commonly causes hyperglycemia, which can further complicate diabetes management.

How serious is the interaction between Alpelisib and Glipizide-metformin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose frequently during alpelisib therapy and increase antidiabetic therapy as needed.

What other medicines interact with Glipizide-metformin?

MediHelp also lists interactions of Glipizide-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Glipizide-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in